Previous Close | 1.4000 |
Open | 1.4000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.3800 - 1.4000 |
52 Week Range | 1.2200 - 2.2600 |
Volume | |
Avg. Volume | 39,989 |
Market Cap | 23.587M |
Beta (5Y Monthly) | 0.83 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.9200 |
Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.67 |
SAN FRANCISCO, Sept. 24, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that it will host an in-person and virtual event for investors and analysts on Tuesday, October 15, 2024, at 8:00 a.m. ET in New York, NY. The event will feature presentations from prominent ophthalmology key opinion leaders (KOLs) and company management. UNITY Biotechnology Ophthalmology D
SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that members of its senior management team will provide a corporate update and participate in one-on-one meetings at the following investor conferences. H.C. Wainwright 4th Annual Ophthalmology Virtual ConferencePresentation Date and Time: Thursday, August 15, 2024 at 7:00 a.m. ETLocation: V